Design (QbD) and Risk Assessment Approach for Formulation and Evaluation of Clobetasol Proionate Nanoemulgel for Anti Psoriatic Activity
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Thesis Boek |
| Taal: | Engels |
| Onderwerpen: | |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
MARC
| LEADER | 00000nam a22000007a 4500 | ||
|---|---|---|---|
| 008 | 230508b |||||||| |||| 00| 0 eng d | ||
| 100 | |a Devadiga Shanaika |9 580 | ||
| 245 | |a Design (QbD) and Risk Assessment Approach for Formulation and Evaluation of Clobetasol Proionate Nanoemulgel for Anti Psoriatic Activity | ||
| 502 | |a M.Pharm. + MBA | ||
| 518 | |a 2023 | ||
| 650 | |a Quality Assurance |9 536 | ||
| 720 | |a Dr. Sanjay Sharma | ||
| 999 | |c 8697 |d 8697 | ||